The Cancer Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Cancer Diagnostics Market?
The global market for cancer diagnostics has seen substantial enlargement recently. The market size stands at $23.24 billion in 2024 and is projected to increase to $25.73 billion in 2025, representing a compound annual growth rate (CAGR) of 10.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Cancer Diagnostics Industry?
The Cancer Diagnostics Global Market is anticipated to reach $40.82 billion in 2029, with a projected compound annual growth rate (CAGR) of 12.2%.
Download Your Free Sample of the 2025 Cancer Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Cancer Diagnostics Market?
The key drivers in the cancer diagnostics market are:
• Emergence and growth in new markets
• Regulatory support for cancer diagnostics
• Integration of artificial intelligence and machine learning in diagnostics
• Focus on early detection and intervention approaches in cancer treatment
Global Market Segmentation: Identifying Major Cancer Diagnostics Industry Segments
The cancer diagnostics market covered in this report is segmented –
1) By Products: Companion Diagnostics, Molecular Diagnostics
2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging
3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications
4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users
Pre-order the 2025 Cancer Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Cancer Diagnostics Market?
The key trends in the cancer diagnostics market are:
• Liquid biopsies are emerging as a significant trend in the market.
• The application of multi-omics approaches is growing.
• The adoption of point-of-care testing is increasingly shaping the market's future.
• There is a rising trend of screening and early intervention campaigns.
Who Are the Top Competitors & Leading Players in the Cancer Diagnostics Market?
Major companies in the cancer diagnostics market are:
• Abbott Laboratories
• Becton Dickinson and Company
• Hologic
• GE Healthcare Ltd.
• Thermo Fisher Scientific
• Siemens Healthcare GmbH
• Accuray
• Elekta AB
• C.R. BardInc.
• Biogenex Laboratories
• Eckert & Ziegler BEBIG
• Veracyte
• PathAI
• Bio-Rad Laboratories
• Biochain
• DiagnoCure
• Illumina
• Myriad Genetics
• CompanionDx
• Epic Sciences
• Eli Lilly and Co
• Genomic Health
• Affymetrix
• Agilent Technologies
• Adaptive Biotechnologies
• Biocartis
• Biocept
• Cancer Genetics Inc.
• Caris Life Sciences
• Cepheid
• Epigenomics AG
• Exact Sciences
• Foundation Medicine
• GenMark Diagnostics
• Guardant Health
• HalioDX
• IBA group
• Invitae Corporation
• Medtronic plc
• NanoString Technologies
• Natera
• NeoGenomics
• Oncura Inc.
• PerkinElmer
• Personal Genome Diagnostics
• Qiagen
• Roche Diagnostics
• Theragenics Corporation
• Varian Medical SystemsInc.
Regional Dominance: Which Area Leads the Global Cancer Diagnostics Market?
North America was the largest region in the cancer diagnostics market in 2023
